Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TCR2 Therapeutics Inc (DE:2K7)
MUNICH:2K7
TCR2 Therapeutics (2K7) Stock Forecast & Price Target
0 Followers
See the Price Targets and Ratings of:
2K7 Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
2K7 Stock 12 Month Forecast
There Are No Analyst Ratings for DE:2K7 In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
2K7 Financial Forecast
Detailed List of Analyst Forecasts
EF Hutton
€1.83
Hold
26.73%
Upside
Reiterated
03/23/23
Analysts Offer Insights on Healthcare Companies: TCR2 Therapeutics (NASDAQ: TCRR) and Inozyme Pharma (NASDAQ: INZY)
Jefferies
€2.74
Hold
90.10%
Upside
Downgraded
03/09/23
Analysts Offer Insights on Healthcare Companies: TCR2 Therapeutics (NASDAQ: TCRR) and Nurix Therapeutics (NASDAQ: NRIX)
Truist Financial
€2.74
Hold
90.10%
Upside
Downgraded
03/07/23
TCR2 Therapeutics downgraded to Hold from Buy at TruistTCR2 Therapeutics downgraded to Hold from Buy at Truist
H.C. Wainwright
―
Hold
―
Downgraded
03/07/23
TCR2 Therapeutics (TCRR) was downgraded to a Hold Rating at H.C. Wainwright
Piper Sandler
€9.14
Buy
533.66%
Upside
Reiterated
01/05/23
TCR2 Therapeutics price target raised to $10 from $8 at Piper SandlerTCR2 Therapeutics price target raised to $10 from $8 at Piper Sandler
SVB Securities
€1.83
Hold
26.73%
Upside
Reiterated
01/05/23
SVB Securities Keeps Their Hold Rating on TCR2 Therapeutics (TCRR)
2K7 Analyst Recommendation Trends
Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
2K7 Stock Forecast FAQ
What is DE:2K7’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:2K7’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:2K7, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TCR2 Therapeutics Inc a Buy, Sell or Hold?
Currently, no data Available
What is TCR2 Therapeutics Inc’s share price target?
Currently, no data Available
What do analysts say about TCR2 Therapeutics Inc?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of TCR2 Therapeutics Inc?
To buy shares of DE:2K7, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.